Genome-Wide Association Study of d-Amphetamine Response in Healthy Volunteers Identifies Putative Associations, Including Cadherin 13 (CDH13)
Open Access
- 28 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e42646
Abstract
Both the subjective response to d-amphetamine and the risk for amphetamine addiction are known to be heritable traits. Because subjective responses to drugs may predict drug addiction, identifying alleles that influence acute response may also provide insight into the genetic risk factors for drug abuse. We performed a Genome Wide Association Study (GWAS) for the subjective responses to amphetamine in 381 non-drug abusing healthy volunteers. Responses to amphetamine were measured using a double-blind, placebo-controlled, within-subjects design. We used sparse factor analysis to reduce the dimensionality of the data to ten factors. We identified several putative associations; the strongest was between a positive subjective drug-response factor and a SNP (rs3784943) in the 8th intron of cadherin 13 (CDH13; P = 4.58×10−8), a gene previously associated with a number of psychiatric traits including methamphetamine dependence. Additionally, we observed a putative association between a factor representing the degree of positive affect at baseline and a SNP (rs472402) in the 1st intron of steroid-5-alpha-reductase-α-polypeptide-1 (SRD5A1; P = 2.53×10−7), a gene whose protein product catalyzes the rate-limiting step in synthesis of the neurosteroid allopregnanolone. This SNP belongs to an LD-block that has been previously associated with the expression of SRD5A1 and differences in SRD5A1 enzymatic activity. The purpose of this study was to begin to explore the genetic basis of subjective responses to stimulant drugs using a GWAS approach in a modestly sized sample. Our approach provides a case study for analysis of high-dimensional intermediate pharmacogenomic phenotypes, which may be more tractable than clinical diagnoses.Keywords
This publication has 82 references indexed in Scilit:
- Translational genetic approaches to substance use disorders: bridging the gap between mice and humansHuman Genetics, 2011
- Genome-Wide Association Scan of Trait DepressionBiological Psychiatry, 2010
- Adiponectin Concentrations: A Genome-wide Association StudyThe American Journal of Human Genetics, 2010
- Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2010
- Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: An exploratory study with d-amphetamine in healthy participants.Experimental and Clinical Psychopharmacology, 2009
- Meta‐analysis of genome‐wide linkage scans of attention deficit hyperactivity disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associationsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Addiction molecular genetics: 639,401 SNP whole genome association identifies many “cell adhesion” genesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- Pooled association genome scanning for alcohol dependence using 104,268 SNPs: Validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholismAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- An association study of the brain‐derived neurotrophic factor Val66Met polymorphism and amphetamine responseAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006